What is Glucobit?
Glucobit, formerly known as Reframe, operates at the intersection of digital health and behavioral science. The company provides a comprehensive mobile application designed to assist individuals in their journey to quit alcohol. By integrating a dynamic recovery program with actionable tools, Glucobit offers a scalable solution to a pervasive public health challenge. Its market position is defined by a focus on user-centric design and evidence-based methodologies, allowing it to compete effectively against traditional recovery programs. The platform's ability to foster long-term behavioral change has attracted significant attention from venture capital firms specializing in consumer technology and health innovation.
How much funding has Glucobit raised?
Glucobit has raised a total of $13.9M across 2 funding rounds:
Angel/Seed
$1.4M
Series A
$12.5M
Angel/Seed (2021): $1.4M with participation from Dave Harrington, Kyle Porter, Chris Klaus, and Atlanta Ventures
Series A (2022): $12.5M led by Goodwater Capital and Atlanta Ventures
Key Investors in Glucobit
Goodwater Capital
A consumer tech investment firm that empowers exceptional entrepreneurs to create positive change in the world, focusing on innovative companies across financial services, retail, and healthcare.
Atlanta Ventures
A firm that empowers entrepreneurs in the Southeastern United States by providing community, content, and capital to help them launch and grow subscription-based companies.
Chris Klaus
An experienced technology investor and entrepreneur known for supporting early-stage ventures and fostering innovation within the startup ecosystem.
What's next for Glucobit?
Looking ahead, Glucobit is poised to leverage its recent capital injection to deepen its market penetration and refine its product offerings. The strategic focus will likely shift toward enhancing user engagement metrics and expanding the platform's feature set to include more personalized recovery pathways. As the company matures, the emphasis will remain on sustainable growth and the potential for broader integration within the healthcare ecosystem. By maintaining its focus on high-impact, subscription-based wellness solutions, Glucobit is set to capitalize on the increasing shift toward digital-first health interventions, aiming to establish itself as a leader in the recovery technology sector.
See full Glucobit company page
